Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Cancer Res ; 48(22): 6491-7, 1988 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-3180066

RESUMO

Ovarian epithelial carcinoma originates from the surface mesothelium. It is controversial whether these tumors possess steroidogenic enzymes, similar to malignancies of other ovarian cell types. This study reports aromatase enzymatic activity for three epithelial cell lines, OV1225, OV166, and 2774, established from patients with ovarian adenocarcinoma. Aneuploidy of the cells was demonstrated by flow cytometric DNA analyses which showed OV1225 tetraploid, OV166 near diploid, and 2774 triploid. Estrogen synthesis was confirmed by measurement of estradiol (6 to 11 pg/10(7) cells/24 h) by radioimmunoassay in extracts of conditioned medium. To directly assay aromatase enzymatic activity, intact cells were incubated with tritiated testosterone. Medium was extracted with organic solvent after addition of trace 14C-labeled 17 beta-estradiol and 14C-labeled estrone. Androgen was separated from estrogen by celite column chromatography. Estrogen was further purified by silica gel thin-layer chromatography and derivatization of separate products to acetates. Purity of compounds was confirmed by consistency of the 3H:14C ratio of acetylated product versus that of product recrystallized with authentic standard. Conversion of testosterone to estradiol proceeded with apparent Michaelis-Menten kinetics. The apparent Km was 4 microM, 15 microM, and 59 microM, and the Vmax was 20 pmol/h/mg of cell protein, 52 pmol/h/mg of cell protein, and 152 pmol/h/mg of cell protein for 2774, OV166, and OV1225, respectively. We conclude that at least a portion of ovarian adenocarcinoma possesses sufficient aromatase activity to convert ovarian stromal androgen to estrogen.


Assuntos
Aromatase/análise , Carcinoma/metabolismo , Neoplasias Ovarianas/metabolismo , Testosterona/metabolismo , Carcinoma/patologia , DNA de Neoplasias/análise , Estradiol/biossíntese , Feminino , Citometria de Fluxo , Humanos , Cinética , Neoplasias Ovarianas/patologia , Células Tumorais Cultivadas/metabolismo
2.
Fertil Steril ; 42(5): 704-8, 1984 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-6208058

RESUMO

Cellular components in peritoneal fluid of infertile patients with and without endometriosis were evaluated in 102 patients with Wright's-Giemsa and Papanicolaou stains. The secretory activity of these cells was studied indirectly by assaying acid phosphatase, prostaglandin (PG) F2 alpha and PGE2 and complement components C3c and C4. The results showed that macrophages and lymphocytes were the dominant cells in peritoneal fluid of these patients. These cells were significantly increased in endometriosis patients, as compared with control subjects. In addition, peritoneal fluid acid phosphatase, PGF2 alpha and PGE2, and complement components C3c and C4 were significantly increased in patients with endometriosis. These cellular changes and their activation in peritoneal fluid may explain infertility associated with endometriosis.


Assuntos
Líquido Ascítico/patologia , Endometriose/patologia , Infertilidade Feminina/patologia , Linfócitos/patologia , Macrófagos/patologia , Neoplasias Peritoneais/patologia , Fosfatase Ácida/análise , Adolescente , Adulto , Líquido Ascítico/metabolismo , Complemento C3/análise , Complemento C3c , Complemento C4/análise , Dinoprosta , Dinoprostona , Endometriose/complicações , Testes de Obstrução das Tubas Uterinas , Feminino , Humanos , Infertilidade Feminina/etiologia , Neoplasias Peritoneais/complicações , Prostaglandinas E/análise , Prostaglandinas F/análise , Coloração e Rotulagem
3.
Cancer ; 67(5): 1326-31, 1991 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-1991295

RESUMO

For patients with ovarian epithelial cancer, survival increases when residual disease approaches zero after surgical removal of the tumor. A previous study using the Cavitron Ultrasonic Surgical Aspirator (CUSA) (Cavitron Lasersonic Corp., Stamford, CT) showed the successful removal of ovarian tumors from areas often considered unresectable: the diaphragm, spleen, stomach, and small bowel. However, the CUSA has not yet been approved by the Food and Drug Administration for gynecologic surgery except on an experimental basis. This study was designed to test whether ultrasonic irradiation produced by the CUSA caused alterations in cell structure or physiology of gynecologic tissue in adjacent areas. Paired tumor samples, unirradiated and irradiated, were obtained from ten patients, and portions were sent for pathologic structural evaluation and physiologic tissue culture evaluation. Histologic sections, stained with hematoxylin and eosin, showed that CUSA irradiation produced only minor tissue distortion as observed under the light microscope. A correct diagnosis would have been made in all cases had only tissue fragments obtained from the CUSA specimen trap been stained. For nine of ten patients, initial tumor cell viability was similar in the two specimen types. Flow cytometric DNA analysis confirmed that surgical methods produced matched samples. Cells that survived high-frequency ultrasound appeared functionally intact. For five of eight patients, the cells from the CUSA specimen traps survived and/or divided to a greater extent than those from the knife-dissected tumors. Cells from both surgical routes attained a similar number of passages in culture. It seems reasonable to extrapolate these in vitro observations with pelvic tumor tissues to normal surrounding tissue left in situ. Thus pelvic tissue is believed to be uninjured by CUSA ultrasonic irradiation.


Assuntos
Neoplasias Ovarianas/diagnóstico por imagem , Neoplasias Ovarianas/patologia , Biópsia por Agulha/métodos , DNA de Neoplasias/análise , Feminino , Citometria de Fluxo , Humanos , Neoplasias Ovarianas/genética , Ploidias , Células Tumorais Cultivadas , Ultrassonografia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa